Aurora Announces Appointment of Chuck Rifici and Adam Szweras to the Board of Directors

20:00 EDT 9 Aug 2015 | Marketwired

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 08/10/15 -- Aurora Cannabis Inc. ("Aurora" or the "Company") (CSE: ACB)(FRANKFURT: 21P)(WKN: A1C4WM)(OTCQB: ACBFF) is pleased to announce the appointment of Chuck Rifici and Adam Szweras to the Board of Directors of the Company.

Mr. Rifici is the co-founder and former CEO of Tweed Marijuana Inc. ("Tweed") and currently a director of the Liberal Party of Canada. Prior to Tweed, he served as CFO of various technology firms such as Select Start Studios (acquired by Shopify), TekSavvy Solutions Inc. and Cybersurf Corp. Mr. Rifici is a chartered professional accountant. He obtained his MBA from Queen's University and a B.A.Sc. in Computer Engineering from the University of Ottawa.

Mr. Szweras has practiced corporate and securities law since 1996. In January 2006, he founded Foundation Markets Inc., a brokerage firm licensed as an Exempt Market Dealer, and FMI Capital Advisory Inc., a merchant bank, where he continues as Chairman. In February 2006, Mr. Szweras joined Fogler, Rubinoff LLP as a partner where he continues to practice corporate and securities law. Mr. Szweras has a LLB from the Osgoode Hall Law School at York University.

Terry Booth, CEO of Aurora, commented, "Aurora is very pleased to have Chuck and Adam on Aurora's Board. They bring to Aurora a wide range of skills and extensive experience with companies from various sectors. Both gentlemen have excellent knowledge of the Cannabis industry in Canada and the United States. They will definitely contribute to the ongoing strength of the Aurora Standard."

About Aurora Cannabis Inc.

Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed producer of medical marijuana pursuant to the Marihuana for Medical Purposes Regulations and operates a 55,200 square foot expandable state-of-the-art production facility in Alberta, Canada. Aurora's wholly-owned subsidiary, Australis Capital Inc., seeks to be an active participant in the U.S. Cannabis market. Aurora trades under the following symbols: (CSE: ACB)(FRANKFURT: 21P)(WKN: A1C4WM)(OTCQB: ACBFF).

On behalf of the Board of Directors,


Terry Booth, CEO

The CSE, securities commission or other regulatory authority has not reviewed, approved or disapproved the contents of this press release. We seek Safe Harbour.

Contacts: Investor Relations Paul J. Searle Toll Free: 1-844-928-7672 (604) 669-9788 (604) 669-9768 (FAX) Media Inquiries Elise Coppens Marketing Director Toll Free: 1-844-928-7672 NEXT ARTICLE

More From BioPortfolio on "Aurora Announces Appointment of Chuck Rifici and Adam Szweras to the Board of Directors "

Quick Search


Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Antiretroviral therapy
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...